These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22817725)

  • 1. Prion processing: a double-edged sword?
    McMahon HE
    Biochem Soc Trans; 2012 Aug; 40(4):735-8. PubMed ID: 22817725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive oxygen species (ROS)-mediated beta-cleavage of the prion protein in the mechanism of the cellular response to oxidative stress.
    Watt NT; Hooper NM
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1123-5. PubMed ID: 16246061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generating recombinant C-terminal prion protein fragments of exact native sequence.
    Johanssen VA; Barnham KJ; Masters CL; Hill AF; Collins SJ
    Neurochem Int; 2012 Feb; 60(3):318-26. PubMed ID: 22197912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The possible role of protein X, a putative auxiliary factor in pathological prion replication, in regulating a physiological endoproteolytic cleavage of cellular prion protein.
    Hachiya NS; Imagawa M; Kaneko K
    Med Hypotheses; 2007; 68(3):670-3. PubMed ID: 17008028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease.
    Zanusso G; Farinazzo A; Fiorini M; Gelati M; Castagna A; Righetti PG; Rizzuto N; Monaco S
    J Biol Chem; 2001 Nov; 276(44):40377-80. PubMed ID: 11682490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
    Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
    J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A traceback phenomenon can reveal the origin of prion infection.
    Kobayashi A; Asano M; Mohri S; Kitamoto T
    Neuropathology; 2009 Oct; 29(5):619-24. PubMed ID: 19659941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel sorting nexin SNX33 interferes with cellular PrP formation by modulation of PrP shedding.
    Heiseke A; Schöbel S; Lichtenthaler SF; Vorberg I; Groschup MH; Kretzschmar H; Schätzl HM; Nunziante M
    Traffic; 2008 Jul; 9(7):1116-29. PubMed ID: 18419754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different prion conformers target the olfactory pathway in sporadic Creutzfeldt-Jakob disease.
    Zanusso G; Ferrari S; Benedetti D; Sbriccoli M; Rizzuto N; Monaco S
    Ann N Y Acad Sci; 2009 Jul; 1170():637-43. PubMed ID: 19686205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute exposure to prion infection induces transient oxidative stress progressing to be cumulatively deleterious with chronic propagation in vitro.
    Haigh CL; McGlade AR; Lewis V; Masters CL; Lawson VA; Collins SJ
    Free Radic Biol Med; 2011 Aug; 51(3):594-608. PubMed ID: 21466851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The octarepeat region of the prion protein is conformationally altered in PrP(Sc).
    Yam AY; Gao CM; Wang X; Wu P; Peretz D
    PLoS One; 2010 Feb; 5(2):e9316. PubMed ID: 20195363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Codon 129 polymorphism and the E200K mutation do not affect the cellular prion protein isoform composition in the cerebrospinal fluid from patients with Creutzfeldt-Jakob disease.
    Schmitz M; Schlomm M; Hasan B; Beekes M; Mitrova E; Korth C; Breil A; Carimalo J; Gawinecka J; Varges D; Zerr I
    Eur J Neurosci; 2010 Jun; 31(11):2024-31. PubMed ID: 20529115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cleavage of the amino terminus of the prion protein by reactive oxygen species.
    McMahon HE; Mangé A; Nishida N; Créminon C; Casanova D; Lehmann S
    J Biol Chem; 2001 Jan; 276(3):2286-91. PubMed ID: 11060296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-sheet constitution of prion proteins.
    Ji HF; Zhang HY
    Trends Biochem Sci; 2010 Mar; 35(3):129-34. PubMed ID: 20060302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
    Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
    Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein.
    Hooper NM
    Biochem Soc Trans; 2005 Apr; 33(Pt 2):335-8. PubMed ID: 15787600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro.
    Tagliavini F; Forloni G; Colombo L; Rossi G; Girola L; Canciani B; Angeretti N; Giampaolo L; Peressini E; Awan T; De Gioia L; Ragg E; Bugiani O; Salmona M
    J Mol Biol; 2000 Jul; 300(5):1309-22. PubMed ID: 10903871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octapeptide repeat region of prion protein (PrP) is required at an early stage for production of abnormal prion protein in PrP-deficient neuronal cell line.
    Sakudo A; Wu G; Onodera T; Ikuta K
    Biochem Biophys Res Commun; 2008 Jan; 365(1):164-9. PubMed ID: 17981146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion protein self-interactions: a gateway to novel therapeutic strategies?
    Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
    Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous prion protein conversion is required for prion-induced neuritic alterations and neuronal death.
    Cronier S; Carimalo J; Schaeffer B; Jaumain E; Béringue V; Miquel MC; Laude H; Peyrin JM
    FASEB J; 2012 Sep; 26(9):3854-61. PubMed ID: 22661006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.